292 related articles for article (PubMed ID: 30414331)
1. The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients.
Campagne O; Mager DE; Brazeau D; Venuto RC; Tornatore KM
Br J Clin Pharmacol; 2019 Mar; 85(3):516-529. PubMed ID: 30414331
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
[TBL] [Abstract][Full Text] [Related]
3. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
[TBL] [Abstract][Full Text] [Related]
4. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.
Zhang HX; Sheng CC; Liu LS; Luo B; Fu Q; Zhao Q; Li J; Liu YF; Deng RH; Jiao Z; Wang CX
Br J Clin Pharmacol; 2019 Apr; 85(4):746-761. PubMed ID: 30597603
[TBL] [Abstract][Full Text] [Related]
5. Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
Ther Drug Monit; 2009 Aug; 31(4):467-74. PubMed ID: 19571775
[TBL] [Abstract][Full Text] [Related]
6. Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients.
Tornatore KM; Meaney CJ; Wilding GE; Chang SS; Gundroo A; Cooper LM; Gray V; Shin K; Fetterly GJ; Prey J; Clark K; Venuto RC
Clin Pharmacokinet; 2015 Apr; 54(4):423-34. PubMed ID: 25511793
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.
Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
Clin Chem; 2001; 47(7):1241-8. PubMed ID: 11427455
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients.
Rong Y; Mayo P; Ensom MHH; Kiang TKL
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):409-422. PubMed ID: 30377942
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients.
Md Dom ZI; Coller JK; Carroll RP; Tuke J; McWhinney BC; Somogyi AA; Sallustio BC
Br J Clin Pharmacol; 2018 Oct; 84(10):2433-2442. PubMed ID: 29974488
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
Clin Pharmacol Ther; 2004 May; 75(5):434-47. PubMed ID: 15116056
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
[TBL] [Abstract][Full Text] [Related]
12. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
Andrews LM; Hesselink DA; van Schaik RHN; van Gelder T; de Fijter JW; Lloberas N; Elens L; Moes DJAR; de Winter BCM
Br J Clin Pharmacol; 2019 Mar; 85(3):601-615. PubMed ID: 30552703
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of mycophenolic acid coadministered with either tasocitinib (CP-690,550) or tacrolimus in adult renal allograft recipients.
Lamba M; Tafti B; Melcher M; Chan G; Krishnaswami S; Busque S
Ther Drug Monit; 2010 Dec; 32(6):778-81. PubMed ID: 20926996
[TBL] [Abstract][Full Text] [Related]
15. Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients.
Gustavsen MT; Midtvedt K; Robertsen I; Woillard JB; Debord J; Klaasen RA; Vethe NT; Bergan S; Åsberg A
Clin Transl Sci; 2020 Nov; 13(6):1327-1335. PubMed ID: 32652886
[TBL] [Abstract][Full Text] [Related]
16. A limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohorts.
Stifft F; Vandermeer F; Neef C; van Kuijk S; Christiaans MHL
Eur J Clin Pharmacol; 2020 May; 76(5):685-693. PubMed ID: 32020321
[TBL] [Abstract][Full Text] [Related]
17. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.
Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E
Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
[TBL] [Abstract][Full Text] [Related]
19. Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique.
van Boekel GA; Donders AR; Hoogtanders KE; Havenith TR; Hilbrands LB; Aarnoutse RE
Eur J Clin Pharmacol; 2015 Jul; 71(7):811-6. PubMed ID: 25980838
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen.
Greanya ED; Poulin E; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Am J Health Syst Pharm; 2012 Jan; 69(2):134-42. PubMed ID: 22215359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
